Budesonide Dosage Recommendations

Asthma Dosing

For mild to moderate asthma in adults, the recommended dose is 200-800 mcg twice daily via metered dose inhaler, depending on severity, as recommended by medical guidelines 1
For children 5-11 years, the recommended dose is 200-400 mcg twice daily via metered dose inhaler, as recommended by medical guidelines 1
For children under 4 years, the FDA-approved budesonide inhalation suspension should be administered twice daily, with a low daily dose of 0.25-0.5 mg total daily dose (0.125-0.25 mg twice daily), a medium daily dose of 0.5-1.0 mg total daily dose (0.25-0.5 mg twice daily), and a high daily dose of >1.0-2.0 mg total daily dose (>0.5-1.0 mg twice daily) 2

For mild to moderate ileal and/or right colonic Crohn's disease, oral budesonide should be started at 9 mg/day as first-line therapy to induce remission, as recommended by the American Gastroenterological Association 3, 4
Patients should be evaluated for response between 4 and 8 weeks to determine if therapy modification is needed, as recommended by the American Gastroenterological Association 3, 4

In patients with mild-moderate ulcerative colitis, standard-dose oral mesalamine or diazo-bonded 5-ASA is suggested rather than budesonide MMX for induction of remission, as recommended by the American Gastroenterological Association 5

For allergic rhinitis in adults, the typical dose is 400 mcg twice daily via nasal spray, as recommended by medical guidelines 1
Rinsing the mouth after use is recommended to prevent oral candidiasis, as recommended by medical guidelines 1

For asthma treatment via nebulizer, use a jet nebulizer with a standard flow rate compressor, as recommended by medical guidelines 2
For young children, use a face mask that fits snugly over the nose and mouth, as recommended by medical guidelines 2
Wash the face after each treatment to prevent local side effects such as oral candidiasis, as recommended by medical guidelines 2

For Crohn's disease, evaluate response between 4 and 8 weeks, as recommended by the American Gastroenterological Association 3, 4
Monitor for local side effects such as oral candidiasis and dysphonia in patients using inhaled formulations, as recommended by medical guidelines 1
In children, monitor growth as suppression of growth velocity has been observed with inhaled corticosteroid use, as recommended by medical guidelines 1